agrees guidant
pharmaceutical johnson johnson medical guidant
guidant producer equipment combats heart implant defibrillators pacemakers aimed offsetting johnson johnson reliance slowing drug mergers drug healthcare industries fragmented johnson johnson patent expirations battling fierce generic defibrillators heart electric shock irregular heartbeat rhythm detected johnson johnson guidant closing antitrust regulators overlapping stent operations stents tubes artery unblocked
